Skip to content
Search
Search
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Statement of Approach
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for April 2025 Hearing
Protocol on the Questioning of Witnesses in Oral Hearing in July 2025
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on Equality, Diversity
and Inclusion
Hearings
Overview
Upcoming hearings
Past Hearings
Logistical Information
Hearings FAQS
Evidence
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Background Presentations to Inquiry Hearings
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Statement of Approach
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for April 2025 Hearing
Protocol on the Questioning of Witnesses in Oral Hearing in July 2025
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on Equality, Diversity
and Inclusion
Hearings
Overview
Upcoming hearings
Past Hearings
Logistical Information
Hearings FAQS
Evidence
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Background Presentations to Inquiry Hearings
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
Quick Exit
Home
Evidence
Hearing Day 19 Evidence
Hearing Day 19 Evidence
Submission date:
13th May 2025
Available Documents (47)
Filter evidence
Exhibit CP-002 - SOP for Placing Patients Outside NCF
(application/pdf: 370.35 KB)
Exhibit CP-003 East of England spec comm beds June 2021
(application/vnd.openxmlformats-officedocument.spreadsheetml.sheet: 18.45 KB)
MIND summary provided by Alice Livermore
(application/pdf: 1.23 MB)
Second Witness Statement of Dr Milind Karale - Inpatient Pathway
(application/pdf: 636.85 KB)
Witness Statement of Clare Panniker for NHSE
(application/pdf: 139 KB)
Witness Statement of Duncan Burton
(application/pdf: 1.35 MB)
Witness Statement of Mark Winstanley for Rethink Mental Illness
(application/pdf: 336.01 KB)
Witness Statement of William Vineall
(application/pdf: 4.22 MB)
DB-019 - Reducing harm from ligatures
(application/pdf: 1.2 MB)
DB-024 - National Framework for Requiring Investigation
(application/pdf: 5.48 MB)
DB-025 - Serious Incident Framework NHS England March 2013
(application/pdf: 757.51 KB)
DB-026 - Serious Incident Framework NHS England March 2015
(application/pdf: 1.48 MB)
DB-027 - Patient Safety Incident Response Framework NHS England August 2022
(application/pdf: 241.65 KB)
DB-030 - The future of NHS patient safety investigations
(application/pdf: 681.57 KB)
DB-031 - Future of NHS patient safety investigations engagement feedback
(application/pdf: 1.66 MB)
DB-033 - B1465-2 Engaging and involving patients, families and staff following a patient safety incident
(application/pdf: 960.26 KB)
DB-035 - B1465-4 Oversight roles and responsibilities specification
(application/pdf: 400.34 KB)
DB-044 - How to Establish a Quality Surveillance Group_ Guidance to the New Health System
(application/pdf: 484.77 KB)
DB-045 - National Guidance on System Quality Groups National Quality Board January 2022
(application/pdf: 1.3 MB)
DB-064 - Five Year Forward View NHS England October 2014
(application/pdf: 911.47 KB)
DB-067 - Culture of care standards for mental health inpatient services
(application/pdf: 1.31 MB)
DB-071 - Preventing suicide in England January 2017
(application/pdf: 1.14 MB)
DB-072 - Suicide prevention in England September 2023
(application/pdf: 1.16 MB)
DB-102 - Five Year Forward View for Mental Health for the NHS in England
(application/pdf: 2.55 MB)
DB-103 - NHS mental health implementation plan 2019/20 - 2023/24
(application/pdf: 1.14 MB)
CTI Summary of DHSC evidence
(application/pdf: 413.81 KB)
CTI Summary of Information from MH Charities
(application/pdf: 682.34 KB)
CTI Summary of NHSE evidence
(application/pdf: 800.57 KB)
MK2-148 CGPG28 - Clinical Risk Assessment Management and Safety Procedure
(application/pdf: 499.34 KB)
MK2-024 EPUT Admissions on Mobius eSOP V5
(application/pdf: 400 KB)
MK2-025 EPUT Admissions on Paris eSOP V7
(application/pdf: 585.86 KB)
MK2-005 MCPG2 - Mental Capacity Act and Deprivation of Liberty Safeguards Procedure
(application/pdf: 540.66 KB)
MK2-010 Advance Statement What I would like to happen if I become unwell
(application/pdf: 863.2 KB)
MK2-014 Welcome Pack
(application/pdf: 2.02 MB)
MK-028 - NEP Clinical Risk Management Protocol September 2004
(application/pdf: 1.94 MB)
MK2-056 Adult Inpatient Psychological Services
(application/pdf: 144.48 KB)
MK2-029 CLP8-Therapeutic Engagement and Supportive Observation
(application/pdf: 23.22 MB)
MK2-142 Explanation of Blanket Rules
(application/pdf: 1.35 MB)
MK2-030 CLP75 - Search Policy
(application/pdf: 1.68 MB)
MK2-144 RMPG05 - Therapeutic and Safe Interventions and De-escalation TASID Procedure
(application/pdf: 593.26 KB)
MK2-067 CG45 Managing Leave for Informal Patients and Patients Detained under the MHA
(application/pdf: 301.62 KB)
MK2-149 CG24 - Discharge and Transfer Clinical Guidelines
(application/pdf: 1.19 MB)
MK2-012 Carers Support Information for Carers friends and families
(application/pdf: 362.25 KB)
MK2-164 CP53 - Freedom to Speak up Whistleblowing Policy
(application/pdf: 289.23 KB)
MK2-234 Larkwood 5 Pillars Quality Review
(application/pdf: 295.61 KB)
MK2-193 Review of Medium Low Secure Services
(application/pdf: 7.2 MB)
MK-015 - EPUT Clinical Risk Assessment and Safety Management Policy 2025
(application/pdf: 1.4 MB)
Other Evidence
Hearing Day 18 Evidence
Hearing Day 21 Evidence
search evidence
Search evidence
View advanced filters
Evidence submission dates
2025 (select all)
View by month
May 2025 (select all)
View by day
15 May 2025
13 May 2025
12 May 2025
08 May 2025
06 May 2025
01 May 2025
Apr 2025 (select all)
View by day
30 Apr 2025
29 Apr 2025
28 Apr 2025
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Statement of Approach
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for April 2025 Hearing
Protocol on the Questioning of Witnesses in Oral Hearing in July 2025
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on Equality, Diversity
and Inclusion
Hearings
Overview
Upcoming hearings
Past Hearings
Logistical Information
Hearings FAQS
Evidence
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Background Presentations to Inquiry Hearings
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
